Skip to main content

MD 150 Pill - white capsule/oblong

Pill with imprint MD 150 is White, Capsule/Oblong and has been identified as Dabigatran Etexilate Mesylate 150 mg. It is supplied by Novadoz Pharmaceuticals LLC.

Dabigatran is used in the treatment of Prevention of Thromboembolism in Atrial Fibrillation; Deep Vein Thrombosis; Deep Vein Thrombosis/Pulmonary Embolism Prophylaxis Following Hip Replacement Surgery; Pulmonary Embolism; Deep Vein Thrombosis, Prophylaxis and belongs to the drug class thrombin inhibitors. Risk cannot be ruled out during pregnancy. Dabigatran 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MD 150

Dabigatran Etexilate Mesylate

Imprint
MD 150
Strength
150 mg
Color
White (white opaque cap and white opaque body)
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Thrombin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novadoz Pharmaceuticals LLC
Manufacturer
MSN Laboratories Private Limited
National Drug Code (NDC)
72205-0204

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.